TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV) - ANVISA Registration 81552290014

Access comprehensive regulatory information for TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81552290014 and manufactured by QINGDAO HIGHTOP BIOTECH CO.,LTD.. The registration is held by SETTY ASSESSORIA E CONSULTORIA EM ASSUNTOS REGULATORIOS LTDA with validity until Mar 18, 2034.

This page provides complete technical specifications for 2 related devices, regulatory compliance details. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
81552290014
2 Related Devices
Registration Details
ANVISA Registration Number: 81552290014
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

FAMÍLIA TESTE RÁPIDO DE ANTICORPO DO VÍRUS DA HEPATITE C PARA HCV
Risk Class IV

Registration Details

81552290014

25351336347202333

26406496000191

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Mar 18, 2024

18/03/2034

09/18/2025 19:00:01

FAMÍLIA TESTE RÁPIDO DE ANTICORPO DO VÍRUS DA HEPATITE C PARA HCV
Risk Class IV

Registration Details

81552290014

25351336347202333

26406496000191

Dates and Status

Mar 18, 2024

18/03/2034

09/18/2025 19:00:01